Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 18, 2023
- Accession no.
- 0001447362-23-000186
- Filed
- Dec 18, 2023
- Trade date
- Dec 14-15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 21 non-derivative transactions. Open-market sales total $497.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Stock | SSaleDisposed | −8,866 | $20.86F2 | −$184,944.76 | 118,152 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −2,795 | $20.86F2 | −$58,303.7 | 95,463 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −2,795 | $20.86F2 | −$58,303.7 | 84,358 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −1,015 | $20.86F2 | −$21,172.9 | 12,867 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −1,019 | $20.86F2 | −$21,256.34 | 12,866 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −1,019 | $20.86F2 | −$21,256.34 | 12,867 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −1,019 | $20.86F2 | −$21,256.34 | 12,860 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −286 | $21.70F9 | −$6,206.2 | 117,866 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −91 | $21.70F9 | −$1,974.7 | 95,372 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −91 | $21.70F9 | −$1,974.7 | 84,267 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −33 | $21.70F9 | −$716.1 | 12,834 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −33 | $21.70F9 | −$716.1 | 12,833 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −33 | $21.70F9 | −$716.1 | 12,834 | Indirect | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −33 | $21.70F9 | −$716.1 | 12,827 | Indirect | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −3,709 | $20.21F10 | −$74,958.89 | 114,157 | Direct | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −322 | $20.21F10 | −$6,507.62 | 95,050 | Indirect | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −322 | $20.21F10 | −$6,507.62 | 83,945 | Indirect | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −117 | $20.21F10 | −$2,364.57 | 12,717 | Indirect | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −117 | $20.21F10 | −$2,364.57 | 12,716 | Indirect | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −118 | $20.21F10 | −$2,384.78 | 12,716 | Indirect | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −117 | $20.21F10 | −$2,364.57 | 12,710 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.61 to $21.58, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $21.61 to $21.76, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $20.05 to $20.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.